BERKELEY, Calif.--(BUSINESS WIRE)--Radar Therapeutics, a biotech company developing smart programmable medicines, today announced the completion of an oversubscribed $13.4 million in seed financing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback